| 產(chǎn)品名稱 | Bupropion hydrochloride - BW 322U | BVF 033 | Amfebutamone |
| 產(chǎn)品貨號(hào) | Axon 1451 CAS [31677-93-7] MF C13H18ClNO.HClMW 276.20 Purity: 99% Soluble in water and DMSO Description A dopamine and noradrenaline reuptake inhibitor and nicotinic acetylcholine receptor antagonist indicated for the treatment of major depressive disorder (MDD) and for the prevention of seasonal major depressive episodes in patients with seasonal affective disorder (SAD) References Certificates Categories Extra info RA Sweet?et al. Pharmacokinetics of single-and multiple dose bupropion in elderly patients with depression. J Clin Pharmacol 1995, 35(9), 876-884. ? RT Segraves et al. Evaluation of sexual functioning depressed outpatients: A double-blind comparison of sustained-release bupropion and sertraline treatment. J Clin Psychopharmacol 2000, 20(2), 122-128. Certificate of Analysis Material Safety Data Sheet CNS DRI Unclassified DRI and NRI; nicotinic acetylcholine receptor antagonist Chemical name 1-(3-Chlorophenyl)-2-[(1,1-dimethylethyl)amino]-1-propanone hydrochloride Parent CAS No. [34911-55-2] Order Size Unit Price Stock 50 mg €85.00 In Stock |
| 產(chǎn)品價(jià)格 | 現(xiàn)貨詢價(jià)，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
Bupropion hydrochloride - BW 322U | BVF 033 | AmfebutamoneAxon 1451 CAS [31677-93-7] MF C13H18ClNO.HCl
Description
A dopamine and noradrenaline reuptake inhibitor and nicotinic acetylcholine receptor antagonist indicated for the treatment of major depressive disorder (MDD) and for the prevention of seasonal major depressive episodes in patients with seasonal affective disorder (SAD)
DRI and NRI; nicotinic acetylcholine receptor antagonist
Chemical name1-(3-Chlorophenyl)-2-[(1,1-dimethylethyl)amino]-1-propanone hydrochloride Parent CAS No.[34911-55-2] |
| 產(chǎn)品資料 |
